ACLY anticorps (pSer454)
Aperçu rapide pour ACLY anticorps (pSer454) (ABIN2883498)
Antigène
Voir toutes ACLY AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer454
-
Specificité
- ATP-Citrate Lyase (Phospho-Ser454) Antibody detects endogenous levels of ATP-Citrate Lyase only when phosphorylated at serine454.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide derived from human ATP-Citrate Lyase around the phosphorylation site of Ser454.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (1:50 - 1:100), Peptide-ELISA (1:1000), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Autre désignation
- ACLY / ATP Citrate Lyase
-
Sujet
-
Name/Gene ID: ACLY
Synonyms: ACLY, ACL, ATP citrate synthase, ATPCL, ATP citrate lyase, ATP-citrate (pro-S-)-lyase, CLATP, ATP-citrate synthase, Citrate cleavage enzyme, Citrate Lyase -
ID gène
- 47
-
UniProt
- P53396
-
Pathways
- L'effet Warburg
Antigène
-